C/A 0001610315 XXXXXXXX 020-36726 LIVE false false false false Changing Flash Perk 4 Start Date to Begin on Day 198 July 21st Oxeia Biopharmaceuticals, Inc. Corporation DE 03-19-2014 361 Newbury Street Boston MA 02115 https://www.oxeiabiopharma.com/ N StartEngine Primary, LLC 0001725012 008-70060 7 - 13 percent One percent (1%) of securities of the total amount of investments raised in the offering, along the same terms as investors. Other Series CF Preferred Stock 25316 0.79000 N/A 19999.64 Y Other At issuer's discretion, with priority given to StartEngine Owners 4999999.27 11-04-2026 2 260456.00 213921.00 2905.00 25477.00 0.00 0.00 12676450.00 7951988.00 0.00 3897661.00 0.00 0.00 0.00 0.00 0.00 0.00 -1246701.00 -1053814.00 AL AK AZ AR CA CO CT DC DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY Oxeia Biopharmaceuticals, Inc. Michael Steven Wyand Chief Executive Officer, Principal Accounting Officer, Director Michael Steven Wyand Chief Executive Officer, Principal Accounting Officer, Director 07-20-2026 Teofilo David Raad Director 07-20-2026 Kartik Kiran Shah Board Member 07-20-2026 Alex Smith Board Member 07-20-2026